Home Dextera Surgical Inc.

Dextera Surgical Inc.

Dextera Surgical Receives Expanded Indication in Solid Organ Surgery for MicroCutter 5/80™

Regarding the benefits, Brendan C. Visser, M.D., associate professor of surgery at Stanford University Medical Center said, “The small size and large degree of articulation provided by the MicroCutter 5/80 is especially beneficial in maneuvering within the confined spaces around solid internal organs." He aded,  “In addition, with the small footprint of the MicroCutter’s jaws, I’m able to successfully operate with less dissection.”

MicroCutter 5/80™ Featured in Presentations at 25th European Conference on General Thoracic Surgery

Dextera Surgical Inc. (Nasdaq:DXTR), a company developing and commercializing the MicroCutter 5/80™ stapler, today announced that its...

Dextera Surgical’s MicroCutter 5/80™ Honored as Finalist in 2017 Medical Design Excellence Awards

“We are incredibly honored to be selected as a finalist in this competitive category and to be...

Dextera Surgical Announces Preliminary Fiscal 2017 Third Quarter Financial Highlights

  Full Financial Results to be Announced May 4, 2017 Dextera Surgical Inc. (Nasdaq:DXTR), a company commercializing and developing...

Dextera Surgical’s MicroCutter 5/80 Featured in Preclinical Laparoscopic Nephrectomy Study at SAGES Annual Meeting

Dextera Surgical Inc. (Nasdaq:DXTR), manufacturer of the smallest-profile and most maneuverable articulating surgical stapling platform on the...